GHELARDONI, SANDRA
 Distribuzione geografica
Continente #
NA - Nord America 6.590
EU - Europa 3.007
AS - Asia 1.283
AF - Africa 106
OC - Oceania 17
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.012
Nazione #
US - Stati Uniti d'America 6.400
IT - Italia 1.158
SE - Svezia 590
CN - Cina 582
SG - Singapore 301
BG - Bulgaria 280
DE - Germania 275
CA - Canada 188
TR - Turchia 170
UA - Ucraina 155
GB - Regno Unito 138
VN - Vietnam 104
FI - Finlandia 94
AT - Austria 86
CI - Costa d'Avorio 81
CH - Svizzera 66
IN - India 41
HK - Hong Kong 39
RU - Federazione Russa 37
FR - Francia 27
BE - Belgio 23
AU - Australia 15
JP - Giappone 15
GR - Grecia 13
NL - Olanda 13
SN - Senegal 13
KR - Corea 11
PL - Polonia 10
CZ - Repubblica Ceca 9
NG - Nigeria 8
DK - Danimarca 7
IR - Iran 7
AF - Afghanistan, Repubblica islamica di 6
ES - Italia 6
RO - Romania 5
PT - Portogallo 4
TW - Taiwan 4
EU - Europa 3
NO - Norvegia 3
BJ - Benin 2
BR - Brasile 2
CL - Cile 2
EE - Estonia 2
IE - Irlanda 2
NZ - Nuova Zelanda 2
PE - Perù 2
BY - Bielorussia 1
CG - Congo 1
DM - Dominica 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
MT - Malta 1
MU - Mauritius 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 11.012
Città #
Woodbridge 974
Ann Arbor 661
Chandler 583
Houston 507
Milan 489
Santa Clara 481
Fairfield 452
Ashburn 355
Sofia 280
Jacksonville 235
Wilmington 203
Singapore 183
Beijing 179
Ottawa 178
New York 176
Cambridge 154
Seattle 152
Serra 146
Boardman 133
Izmir 130
Princeton 127
Nanjing 123
Lawrence 109
Vienna 82
Abidjan 81
Medford 74
Dong Ket 67
Bern 65
Frankfurt am Main 57
Dearborn 53
Des Moines 51
Pisa 51
Bremen 49
Redwood City 48
Jüchen 45
Florence 44
Rome 44
Istanbul 38
Hong Kong 35
London 33
Nanchang 33
San Diego 30
Kunming 29
Boulder 28
Pune 25
Chicago 23
Brussels 22
Falls Church 21
Lancaster 18
Los Angeles 17
Shenyang 16
Tianjin 16
Ogden 15
Renton 15
Changsha 14
Norwalk 14
Washington 14
Dakar 13
Hebei 13
Hefei 13
Jiaxing 12
Hangzhou 10
Orange 10
Dallas 9
Fuzhou 9
Guangzhou 9
Shanghai 9
Chengdu 8
Lagos 8
Guiyang 7
Livorno 7
Hobart 6
Quanzhou 6
Rødovre 6
Trezzo Sull'adda 6
Auburn Hills 5
Melbourne 5
Saffron Walden 5
San Francisco 5
Santo Stefano D'aveto 5
Spoltore 5
Tappahannock 5
Tokyo 5
Warsaw 5
Wuhan 5
Bogen 4
Changchun 4
Essen 4
Kent 4
Madison 4
Pietrasanta 4
Baleia 3
Berlin 3
Boston 3
Charleston 3
Costa Mesa 3
Düsseldorf 3
Montignoso 3
Ningbo 3
North York 3
Totale 8.539
Nome #
3-Iodothyronamine modulates sarcoplasmic reticulum calcium release 170
Stimulation of cardiac trace amine receptors by 3-iodothyronamine modulates tyrosine phosphorylation and induces cardioprotection 161
Exogenous 3-iodothyronamine rescues the entorhinal cortex from β-amyloid toxicity 161
EFFECTS OF ALTERED GRAVITY ON STEM CELL BIOLOGY AND TISSUE REGENERATION IN THE PRESENCE OF CERIUM OXIDE NANOPARTICLES 159
Stimulation of cardiac trace amine receptors by 3-iodothyronamine modulates tyrosine phosphorylation and induces cardioprotection 148
Cardioprotection by 3-iodothyronamine, a new endogenous chemical messenger 148
3-Iodothyronamine as a novel endogenous chemical messenger: tissue distribution and catabolism 146
3-Iodothyronamine (T(1)AM) induces variation in phosphorylation pattern of tyrosine residues in rat heart 145
3-Iodothyronamine as a Novel Endogenous Chemical Messenger: Tissue Distribution and Catabolism. 144
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum: a feasibility study 143
Cardioprotective effect of 3-iodothyronamine in perfused rat heart subjected to ischemia and reperfusion. 140
Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart 139
Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors 137
Modulation of Cardiac Inotropic State by 3-Iodothyronamine: Evidence for a Novel Signalling Pathway Mediated by Trace Amine-Associated Receptors 136
Effect of MEN 10755, a new disaccharide analogue of doxorubicin, on sarcoplasmic reticulum Ca(2+) handling and contractile function in rat heart 136
S-nitrosothiol detection in isolated perfused rat heart 133
Modulation of sarcoplasmic reticulum calcium channel by adenosine: a PKC-dependent pathway 132
3-Iodothyronamine Modulates Sarcoplasmic Reticulum Calcium Release 132
A new signalling pathway mediated by 3-iodothyronamine in rat heart 132
Effects of 3-iodothyronamine (T1AM) on signaling pathways involved in synaptic plasticity and neuroprotection. 132
Topiramate does not alter expression in rat brain of enzymes of arachidonic acid metabolism 129
Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors. 128
Metabolic reprogramming by 3-Iodothyronamine (T1AM): a new perspective to reverse obesity through co-regulation of sirtuin 4 and 6 expression 128
A1 receptor stimulation induces changes in calcium homeostasis 124
3-Iodothyronamine (T1AM) signalling pathway involves tyrosine phosphorylation in rat heart 124
A3 adenosine receptor stimulation modulates sarcoplasmic reticulum Ca2+ release in rat heart 124
Cardioprotective effect of growth hormone secretagogues in rat heart 123
Characterization of 3-Iodothyronamine In Vitro Dynamics by Mathematical Modeling 123
Cardioprotection by ranolazine in perfused rat heart 123
WEIGHT LOSS WITH PRESERVED GLUCOSE HOMEOSTASIS DURING CHRONIC TREATMENT OF OBESE MICE WITH 3-IODOTHYRONAMINE (T1AM): ROLE OF THE SIRTUIN FAMILY 122
A1 adenosine receptor stimulates phospholamban expression 120
3-Iodothyronamine (T1AM) induces variation in the phosphorylation pattern of thyrosine residues in rat heart 119
Effects of A1 adenosine receptor stimulation on the expression of genes involved in calcium homeostasis 119
3-Iodothyronamine (T1AM) modifies tyrosine phosphorylation pattern in rat heart 118
3-iodothyronamine as a potential anti-tumor compound 117
Cardioprotective effect of growth hormone secretagogues in rat heart 114
Evaluation of 3-iodothyronamine (T1AM) in cell preparation, tissue homogenates and biological fluids by HPLC-ESI-MS-MS 113
Modulation of the cardiac sarcoplasmic reticulum release by adenosine: a protein kinase C-dependent pathway 112
Tissue Distribution and Cardiac Metabolism of 3-Iodothyronamine 112
Modulation of cardiac inotropic state by 3-iodothyronamine: evidence for a novel signalling pathway mediated by trace amine-associated receptors 110
Cardiac effects of trace amines: Pharmacological characterization of trace amine-associated receptors 110
Modulation of cardiac calcium homeostasis by 3-iodothyronamine 110
Preconditioning by adenosine is associated with increased sarcoplasmic reticulum phospholamban expression 109
Cardiac metabolism of 3-iodothyronamine 109
3,5-diiodo-L-thyronine increases glucose consumption in cardiomyoblasts without affecting the contractile performance in rat heart 109
Deciphering the potential of 3-iodothyronamine (T1AM) in regulating lipid metabolism 107
Recovery of 3-iodothyronamine and derivatives in biological matrices: problems and pitfalls 107
Cross-talk” between L-type sarcolemmal calcium channels and sarcoplasmic reticulum calcium release channels in rat myocardium 106
Cardiac effects of thyronamines 106
Preconditioning by adenosine is associated with increased sarcoplasmic reticulum phopsholamban expression 104
Cardiac Functional Effects of 3-Iodothyronamine, a New Endogenous Thyroid Hormone Derivative 104
Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat 102
Effect of 3-iodothyronamine on myocardial calcium homeostasis 101
Effects of 3-Iodothyronamine on Sarcoplasmic Reticulum Calcium Release in Rat Heart 99
3-Iodothyronamine cardiac metabolism: new insights resulting from liquid chromatography tandem mass spectrometry analysis 99
T1AM A MASTER REGULATOR AND A POTENTIAL DRUG OF SIRTUIN PROTEINS: APPLICATIONS TO AGING AND CANCER 98
Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function 97
Biochemical basis of ischemic heart injury and of cardioprotective interventions 97
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum. 96
Up-take of thyronines and 3-iodothyronamine in liver cells 95
Effects of Zofenopril on Cardiac Sarcoplasmic Reticulum Calcium Handling 95
3-iodothyronamine (T1AM) induces changes on glutamatergic postsynaptic signaling pathway 95
Cardioprotective effect of zofenopril in perfused rat heart subjected to ischemia and reperfusion 94
Ca2+ channel remodelling in perfused heart: effects of mechanical work and interventations affecting Ca2+ cycling on sarcolemmal and sarcoplasmic reticulum Ca2+ channels 94
Cardioprotection and energy metabolism modulation by 3-iodothyronamine, a new endogenous chemical messanger 93
New insights into the thyroid endocrine system by HPLC-ESI-MS-MS 93
Modulation of calcium channel expression in rat myocardium by work load 93
Ca2+-induced remodeling of Ca2+ channels in myocardium 92
New insights into 3-iodothyronamine (T1AM) cardiac metabolism by LC/MS/MS 92
Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain 92
3-iodothyronamine is a novel endogenous modulator of cardiac function 91
3-Iodothyronamine cardiac metabolism: new insights resulting from liquid chromatography tandem mass spectrometry analysis 90
A3 adenosine receptor stimulation modulates sarcoplasmic reticulum calcium release, 89
Short-term effects of pressure overload on the expression of genes involved in calcium homeostasis 88
Chronic carbamazepine decreases the expression and the activity of cytosolic phospholipase A2 in rat brain 86
Modulation of sarcoplasmic reticulum calcium channel by adenosine: a PKC-dependent pathway 85
Ghrelin tissue distribution: comparison between gene and protein expression 85
Uptake and metabolic effects of 3-iodothyronamine (T1AM) in hepatocytes 85
Detecting 3-iodothyronamine in the presence of fetal bovine serum: isotope kinetic effect and other pitfalls 85
Effects of 3-iodothyronamine (T1AM) on long term potentiation (LTP) postsynaptic signaling cascade 83
New insights into the thyroid endocrine system by HPLC-ESI-MS-MS 82
Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart 81
Modulation of cardiac ionic homeostasis by 3-iodothyronamine 81
Late preconditioning by adenosine is associated with reduced sarcoplasmic reticulum calcium uptake 79
Cardioprotection by A3 adenosine agonists: role of sarcoplasmic reticulum calcium release 78
Cardioprotection by 3-iodothyronamine, a new endogenous chemical messanger 77
Effects of 3,5-diiodo-L-thyronine on the cardiac tissue 76
Melanin-concentrating hormone (MCH) neurons in the developing chick brain 74
3-Iodothyronamine and 3,5,3’-triiodo-L-thyronine reduce SIRT1 protein expression in HepG2 cell line. 74
3-Iodothyronamine (T1AM), an endogenous fast acting thyroid hormone derivative: novel evidence for weight loss and glucose co-regulation by RNA gene expression 73
Effect of acute and chronic zofenopril administration on cardiac calcium homeostasis 73
Metabolic effects of 3-iodothyronamine in hepatocytes 71
Selective downregulation of brain cytosolic phospholipase A2 activity and protein in rats treated chronically with carbamazepine 69
Low dose 3-iodothyronamine increases acute lipolysis followed by protein catabolism in mouse 67
Modulation of L-type calcium channel expression by sarcoplasmic reticulum calcium release 67
Metabolome dynamics of T1AM, an endogenous thyroid hormone derivative: Effects on lipid metabolism, weight loss, and appetite in mice. 61
Resveratrol and catechin protect PC12 cells from beta-amyloid toxicity 57
Artificially altered gravity elicits cell homeostasis imbalance in planarian worms, and cerium oxide nanoparticles counteract this effect 57
3-iodothyronamine (T1AM) is taken up and rapidly metabolized in neuronal cells 55
Cardioprotective effect of ghrelin receptor stimulation 53
Totale 10.546
Categoria #
all - tutte 29.194
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.194


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020851 0 0 0 0 0 173 159 103 153 96 145 22
2020/2021799 86 22 71 46 101 61 56 74 60 51 38 133
2021/20221.136 17 83 23 56 220 160 29 46 53 51 90 308
2022/20231.732 223 243 130 191 189 224 8 107 283 8 94 32
2023/20241.515 218 198 186 128 241 245 43 41 30 27 38 120
2024/2025977 38 173 41 162 397 166 0 0 0 0 0 0
Totale 11.167